Indications and uses
relieves: occasional constipation (irregularity)
Senna-Lax
- Manufacturer
- Guardian Drug Company
- Effective date
- 2024-12-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:47:55
Label at a glance#
ProductSenna-Lax
Active ingredientSENNOSIDES
Label structure9 sections
Dosage and administration
take preferably at bedtime expect results in 6-12 hours adults and children 12 years and over do not exceed 8 tablets in 24 hours children 6 to under 12 years do not exceed 4 tablets in 24 hours children 2 to under 6 years do not exceed 2 tablets in 24 hours do not exceed the maximum dosage of this product adults and children 12 years and over 2 tablets once daily (maximum: 4 tablets twice a day) children 6 to ...
Storage and handling
do not use if printed seal under cap is torn or missing store at room temperature avoid excessive humidity
Label contents#
Full prescribing information#
Active ingredient (in each tablet)
Sennosides 8.6 mg
Purpose
Laxative
Uses
relieves: occasional constipation (irregularity)
WARNINGS SECTION
Do not use
- laxative products for longer than 1 week unless directed by a doctor
Ask a doctor before use if you have
- abdominal pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues over a period of 2 weeks
stop use and ask a doctor if
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use
keep out of reach of children. In case of overdose, get medical help or contact a poison control center immediately.
Directions
- take preferably at bedtime
- expect results in 6-12 hours
- adults and children 12 years and over do not exceed 8 tablets in 24 hours
- children 6 to under 12 years do not exceed 4 tablets in 24 hours
- children 2 to under 6 years do not exceed 2 tablets in 24 hours
- do not exceed the maximum dosage of this product
| adults and children 12 years and over | 2 tablets once daily (maximum: 4 tablets twice a day) |
| children 6 to under 12 years | 1 tablet once daily (maximum: 2 tablets twice a day) |
| children 2 to under 6 years | 1/2 tablet once daily (maximum: 1 tablet twice a day) |
| childrem under 2 years | ask a doctor |
Other information
- do not use if printed seal under cap is torn or missing
- store at room temperature
- avoid excessive humidity
Inactive ingredients
crospovidone, dextrose, magnesium stearate, microcrystalline cellulose, pregelatinized starch
PDP
Compare to the active ingredient in SENOKOT®
Senna-Lax
Natural Vegetable Laxative
Sennosides / Laxative
For Gentle, Overnight
Relief of Constipation
100 Tablets
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53041-159-14 | Senna-Lax | 1 in 1 CARTON | TABLET | 1 | 4 | |
| 53041-159-14 | Senna-Lax | 50 in 1 BOTTLE | TABLET | 50 | 4 | |
| 53041-159-16 | Senna-Lax | 1 in 1 CARTON | TABLET | 1 | 4 | |
| 53041-159-16 | Senna-Lax | 100 in 1 BOTTLE | TABLET | 100 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SENNOSIDES | ACTIVE INGREDIENT | 3FYP5M0IJX | 1 | |
| SENNOSIDES | ACTIVE MOIETY | 3FYP5M0IJX | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1 |
Products#
Every source-derived product name is available through these pages.
- Senna-Lax
- Sennosides
- CROSPOVIDONE
- DEXTROSE
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE
- STARCH, PREGELATINIZED CORN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53041-159 | 53041-159-14, 53041-159-16 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CROSPOVIDONE | 2S7830E561 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| STARCH, PREGELATINIZED CORN | O8232NY3SJ | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna-Lax | SENNOSIDES | Guardian Drug Company | d3ee7288-986e-44a6-8aa2-05405210c875 | 2024-12-19 | Warnings | 53041-159-14 53041-159-16 53041-159 53041015916 53041015914 dd385d1a-6a28-46fa-bebe-447985c71135 d3ee7288-986e-44a6-8aa2-05405210c875 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.